SEB Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$41.6M Sell
178,606
-4,300
-2% -$994K 0.15% 124
2026
Q2
$38.8M Buy
182,906
+42,955
+31% +$8.43M 0.15% 129
2026
Q1
$27.4M Buy
+139,951
New +$27.2M 0.12% 154

Other funds holding DGX

SEB Asset Management's DGX Position: Q3 2026 in Review

SEB Asset Management reduced its Quest Diagnostics (DGX) stake by 2.4% in Q3 2026, selling an estimated $994K and leaving 178,606 shares worth $41.6M. The position accounts for 0.15% of the portfolio, ranked #124.

SEB Asset Management first reported a position in DGX in Q1 2026 and has held it in 3 quarters since. 1,137 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • SEB Asset Management held 178,606 shares of Quest Diagnostics worth $41.6M as of Q3 2026.
  • SEB Asset Management sold 4,300 Quest Diagnostics shares in Q3 2026, an estimated $994K.
  • Quest Diagnostics made up 0.15% of SEB Asset Management's portfolio in Q3 2026, its #124 holding.
  • SEB Asset Management first reported a position in Quest Diagnostics in Q1 2026 and has held it in 3 quarters since.
  • 1,137 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.